231 related articles for article (PubMed ID: 8396630)
1. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.
Adams JU; Tallarida RJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 1993 Sep; 266(3):1261-7. PubMed ID: 8396630
[TBL] [Abstract][Full Text] [Related]
2. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
3. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
4. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
5. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB).
Malmberg AB; Yaksh TL
J Pharmacol Exp Ther; 1992 Oct; 263(1):264-75. PubMed ID: 1328610
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
[TBL] [Abstract][Full Text] [Related]
7. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
8. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
9. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
Suh HH; Tseng LF
Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
[TBL] [Abstract][Full Text] [Related]
11. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
Calcagnetti DJ; Holtzman SG
Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444
[TBL] [Abstract][Full Text] [Related]
12. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
13. Synergy between mu/delta-opioid receptors mediates adenosine release from spinal cord synaptosomes.
Cahill CM; White TD; Sawynok J
Eur J Pharmacol; 1996 Feb; 298(1):45-9. PubMed ID: 8867918
[TBL] [Abstract][Full Text] [Related]
14. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
Hammond DL; Stewart PE; Littell L
J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
[TBL] [Abstract][Full Text] [Related]
15. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
Shook JE; Pelton JT; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
Chen X; Geller EB; Adler MW
Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
[TBL] [Abstract][Full Text] [Related]
17. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
[TBL] [Abstract][Full Text] [Related]
18. Mu-delta opioid interactions. III: Differential antagonism of DPDPE-induced increases in morphine EEG and EEG power spectra by DALCE and naltrindole.
Stamidis H; Young GA
Peptides; 1993; 14(3):511-7. PubMed ID: 8392719
[TBL] [Abstract][Full Text] [Related]
19. Acute cross-tolerance to opioids in heroin delta-opioid-responding Swiss Webster mice.
Rady JJ; Fujimoto JM
J Biomed Sci; 2000; 7(3):258-69. PubMed ID: 10810246
[TBL] [Abstract][Full Text] [Related]
20. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
